Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use

NCT03842436 is registered in ClinicalTrials.gov with Brigham and Women's Hospital as lead sponsor.

NCT NCT03842436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03842436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility and Acceptability of Digital Pills to Monitor PrEP Adherence in MSM With Substance Use
Lead sponsor
Brigham and Women's Hospital
Phase
Phase 4
Overall status
Completed
Start date
October 1, 2018
Completion date
April 22, 2020
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adherence, medication, hiv/aids, substance use disorders